Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Influence of chemotherapeutic drug-related gene polymorphisms on toxicity and survival of early breast cancer patients receiving adjuvant chemotherapy.

Ludovini V, Antognelli C, Rulli A, Foglietta J, Pistola L, Eliana R, Floriani I, Nocentini G, Tofanetti FR, Piattoni S, Minenza E, Talesa VN, Sidoni A, Tonato M, Crinò L, Gori S.

BMC Cancer. 2017 Jul 26;17(1):502. doi: 10.1186/s12885-017-3483-2.

2.

 GSTT1, GSTM1, and GSTP1 polymorphisms as a prognostic factor in women with breast cancer.

Oliveira AL, Oliveira Rodrigues FF, Dos Santos RE, Rozenowicz RL, Barbosa de Melo M.

Genet Mol Res. 2014 Jan 22;13(2):2521-30. doi: 10.4238/2014.January.22.9.

3.

Genetic polymorphisms of CYP2E1, GST, and NAT2 enzymes are not associated with risk of breast cancer in a sample of Lebanese women.

Zgheib NK, Shamseddine AA, Geryess E, Tfayli A, Bazarbachi A, Salem Z, Shamseddine A, Taher A, El-Saghir NS.

Mutat Res. 2013 Jul-Aug;747-748:40-7. doi: 10.1016/j.mrfmmm.2013.04.004. Epub 2013 Apr 27.

PMID:
23628324
4.

GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.

Oliveira AL, Rodrigues FF, Santos RE, Aoki T, Rocha MN, Longui CA, Melo MB.

Genet Mol Res. 2010 Jun 11;9(2):1045-53. doi: 10.4238/vol9-2gmr726.

5.

Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.

Cheng TC, Chen ST, Huang CS, Fu YP, Yu JC, Cheng CW, Wu PE, Shen CY.

Int J Cancer. 2005 Jan 20;113(3):345-53.

6.

Current researches on breast cancer epidemiology in Korea.

Yoo KY, Kang D.

Breast Cancer. 2003;10(4):289-93. Review.

PMID:
14634505
7.

The interaction between alcohol consumption and GSTM1 genotype on polycyclic aromatic hydrocarbon-DNA adduct levels in breast tissue.

Rundle A, Tang D, Mooney L, Grumet S, Perera F.

Cancer Epidemiol Biomarkers Prev. 2003 Sep;12(9):911-4.

8.

Association between a glutathione S-transferase A1 promoter polymorphism and survival after breast cancer treatment.

Sweeney C, Ambrosone CB, Joseph L, Stone A, Hutchins LF, Kadlubar FF, Coles BF.

Int J Cancer. 2003 Mar 1;103(6):810-4.

Supplemental Content

Loading ...
Support Center